On June 6, 2005, Edwards Lifesciences submitted to the
New York Stock Exchange a certification signed by its Chief Executive
Officer that as of June 3, 2005 he was not aware of any violation
by Edwards Lifesciences of the NYSE corporate governance listing
standards. In addition, the certifications signed by the Chief
Executive Officer and Chief Financial Officer required under Section
302 of the Sarbanes-Oxley Act were filed as an exhibit to Edwards’ Annual
Report on Form 10-K for the year ended December 31, 2005.